This VYGR PE ratio history page last updated 6/20/2025

Period | Price | GAAP | TTM | PE |
Q1 2025 5/6/2025 | 3.25 | -0.53 | -1.46 | NA | Q4 2024 3/11/2025 | 3.97 | -0.59 | -1.13 | NA | Q3 2024 11/12/2024 | 6.83 | -0.16 | 0.71 | 9.6 | Q2 2024 8/6/2024 | 8.19 | -0.18 | 0.28 | 29.2 | Q1 2024 5/13/2024 | 8.48 | -0.20 | -0.05 | NA | Q4 2023 2/28/2024 | 8.97 | 1.25 | 3.09 | 2.9 | Q3 2023 11/6/2023 | 6.49 | -0.59 | 1.23 | 5.3 | Q2 2023 8/3/2023 | 9.31 | -0.51 | 2.27 | 4.1 | Q1 2023 5/9/2023 | 10.76 | 2.94 | 2.28 | 4.7 | Q4 2022 3/7/2023 | 7.34 | -0.61 | -1.22 | NA | Q3 2022 11/8/2022 | 5.25 | 0.45 | -0.46 | NA | Q2 2022 8/4/2022 | 7.47 | -0.50 | -1.58 | NA | Q1 2022 5/4/2022 | 8.52 | -0.56 | -1.88 | NA | Q4 2021 3/8/2022 | 5.24 | 0.15 | -1.90 | NA | Q3 2021 11/2/2021 | 3.89 | -0.67 | -2.48 | NA | Q2 2021 8/6/2021 | 3.31 | -0.80 | 0.46 | 7.2 | Q1 2021 5/10/2021 | 4.11 | -0.58 | 1.03 | 4.0 | Q4 2020 2/25/2021 | 6.23 | -0.43 | 0.95 | 6.6 | Q3 2020 11/9/2020 | 11.20 | 2.27 | 1.04 | 10.8 | Q2 2020 8/10/2020 | 11.18 | -0.23 | -1.64 | NA | Q1 2020 5/6/2020 | 11.36 | -0.66 | -1.12 | NA | Q4 2019 3/3/2020 | 11.58 | -0.34 | -1.27 | NA | Q3 2019 11/6/2019 | 13.77 | -0.41 | -1.63 | NA | Q2 2019 8/9/2019 | 20.53 | 0.29 | -1.85 | NA | Q1 2019 5/7/2019 | 23.52 | -0.81 | -2.94 | NA | Q4 2018 2/26/2019 | 13.87 | -0.70 | -2.76 | NA | Q3 2018 11/7/2018 | 13.99 | -0.63 | -2.46 | NA | Q2 2018 8/7/2018 | 20.18 | -0.80 | -2.72 | NA | Q1 2018 5/10/2018 | 16.76 | -0.63 | -2.65 | NA | Q4 2017 3/14/2018 | 23.16 | -0.40 | -2.67 | NA | Q3 2017 11/2/2017 | 18.90 | -0.89 | -2.84 | NA | Q2 2017 8/8/2017 | 8.78 | -0.73 | NA | NA | Q1 2017 5/9/2017 | 8.97 | -0.65 | NA | NA | Q4 2016 3/15/2017 | 11.21 | -0.57 | NA | NA |
|

Period | Price | GAAP | Annualized | PE |
Q1 2025 5/6/2025 | 3.25 | -0.53 | -2.12 | NA | Q4 2024 3/11/2025 | 3.97 | -0.59 | -2.36 | NA | Q3 2024 11/12/2024 | 6.83 | -0.16 | -0.64 | NA | Q2 2024 8/6/2024 | 8.19 | -0.18 | -0.72 | NA | Q1 2024 5/13/2024 | 8.48 | -0.20 | -0.80 | NA | Q4 2023 2/28/2024 | 8.97 | 1.25 | 5.00 | 1.8 | Q3 2023 11/6/2023 | 6.49 | -0.59 | -2.36 | NA | Q2 2023 8/3/2023 | 9.31 | -0.51 | -2.04 | NA | Q1 2023 5/9/2023 | 10.76 | 2.94 | 11.76 | 0.9 | Q4 2022 3/7/2023 | 7.34 | -0.61 | -2.44 | NA | Q3 2022 11/8/2022 | 5.25 | 0.45 | 1.80 | 2.9 | Q2 2022 8/4/2022 | 7.47 | -0.50 | -2.00 | NA | Q1 2022 5/4/2022 | 8.52 | -0.56 | -2.24 | NA | Q4 2021 3/8/2022 | 5.24 | 0.15 | 0.60 | 8.7 | Q3 2021 11/2/2021 | 3.89 | -0.67 | -2.68 | NA | Q2 2021 8/6/2021 | 3.31 | -0.80 | -3.20 | NA | Q1 2021 5/10/2021 | 4.11 | -0.58 | -2.32 | NA | Q4 2020 2/25/2021 | 6.23 | -0.43 | -1.72 | NA | Q3 2020 11/9/2020 | 11.20 | 2.27 | 9.08 | 1.2 | Q2 2020 8/10/2020 | 11.18 | -0.23 | -0.92 | NA | Q1 2020 5/6/2020 | 11.36 | -0.66 | -2.64 | NA | Q4 2019 3/3/2020 | 11.58 | -0.34 | -1.36 | NA | Q3 2019 11/6/2019 | 13.77 | -0.41 | -1.64 | NA | Q2 2019 8/9/2019 | 20.53 | 0.29 | 1.16 | 17.7 | Q1 2019 5/7/2019 | 23.52 | -0.81 | -3.24 | NA | Q4 2018 2/26/2019 | 13.87 | -0.70 | -2.80 | NA | Q3 2018 11/7/2018 | 13.99 | -0.63 | -2.52 | NA | Q2 2018 8/7/2018 | 20.18 | -0.80 | -3.20 | NA | Q1 2018 5/10/2018 | 16.76 | -0.63 | -2.52 | NA | Q4 2017 3/14/2018 | 23.16 | -0.40 | -1.60 | NA | Q3 2017 11/2/2017 | 18.90 | -0.89 | -3.56 | NA | Q2 2017 8/8/2017 | 8.78 | -0.73 | -2.92 | NA | Q1 2017 5/9/2017 | 8.97 | -0.65 | -2.60 | NA | Q4 2016 3/15/2017 | 11.21 | -0.57 | -2.28 | NA |
|
On this page we presented the VYGR PE Ratio History information for Voyager Therapeutics' stock.
The average VYGR PE ratio history based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 5.5. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average VYGR PE ratio history based on this TTM earnings result method is 8.4. Note: any PE calculations involving negative earnings were discarded as not meaningful.
Let's now compare this VYGR PE ratio history result, against the recent PE: when this page was posted on 6/18/2025, the most recent closing price for VYGR had been 3.04, and the most recent quarterly earnings result, annualized, was 5. Meanwhile, the most recent TTM earnings summed to 0.71. From these numbers, we calculate the recent VYGR PE on 6/18/2025 based on annualized quarterly EPS was 0.6. Based on VYGR's history, that recent PE is low relative to the historical average, with the recent PE 89.1% lower than the historical average PE across our data set for Voyager Therapeutics. Looking at the recent VYGR PE on 6/18/2025 based on TTM EPS, we calculate the ratio at 4.3. Based on VYGR's history, that recent PE is low relative to the historical average, with the recent PE 48.8% lower than the average PE across our Voyager Therapeutics data set with TTM EPS used in the calculation at each period.
For self directed investors doing their due diligence on VYGR or any other given stock, valuation analysis for VYGR
can greatly benefit from studying the past earnings and resulting PE ratio history calculations. This type of study can
help inform an analysis as to whether the earnings trajectory over time and current versus historical average PE ratios
justify the current stock market value.
That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate
Voyager Therapeutics PE ratio history — or the PE history for any stock in our coverage universe.
And in your continued research we hope you will be sure to check out the further links included for
next earnings dates and also historical earnings surprises history for VYGR. Thanks for visiting, and the next
time you need to research VYGR PE Ratio History or the PE ratio history for another stock, we hope our site
will come to mind as your go-to PE ratio history research resource of choice.